This evidence demonstrates that fucosterol may produce similar LXR-β-mediated effects to aid in brain cholesterol homeostasis and play a pivotal role against AD pathology involving Aβ clearance via ABC/SHREBP1/ApoE-dependent pathways (Figure 3). This evidence concerns the gene APOE and Alzheimer disease.